Skip to Main Content

Paper Details

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.
NPJ Precis Oncol
9
2022
3D tumor tissue cultures, ALK, BRAF, MET, TP53, multicellular fresh tumor tissue spheroid cultures, patients, pediatric cancer, tumor
Author NameAffiliation
Martin SillHopp Children's Cancer Center Heidelberg (KiTZ)
Martin SillGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Christopher PrevitiHopp Children's Cancer Center Heidelberg (KiTZ)
Christopher PrevitiGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Christopher PrevitiGerman Cancer Research Center (DKFZ)
Gnana Prakash BalasubramanianHopp Children's Cancer Center Heidelberg (KiTZ)
Gnana Prakash BalasubramanianGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Nicolas U GerberUniversity Children's Hospital Zurich
Johannes GojoComprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna
Caroline HutterSt. Anna Children's Hospital, Medical University of Vienna
Caroline HutterSt. Anna Children's Cancer Research Institute (CCRI)
Ingrid ÿraChildren's Hospital, Skane University Hospital, Lund & Karolinska University Hospital
Frank WestermannHopp Children's Cancer Center Heidelberg (KiTZ)
Frank WestermannGerman Cancer Research Center
Norbert GrafSaarland University Medical Center
Norbert GrafSaarland University Medical Center
Michaela Nathrath
Michaela NathrathDepartment of Pediatrics and Children's Cancer Research Center, Technical University of Munich
Christof M KrammUniversity Medical Center Gottingen
Uta DirksenWest German Cancer Center German Cancer Consortium (DKTK), University Hospital Essen
Uta DirksenWest German Cancer Center German Cancer Consortium (DKTK), University Hospital Essen
Olli KallioniemiInstitute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki
Olli KallioniemiUniversity of Helsinki
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHeidelberg University Hospital
Cornelis M van TilburgHopp Children's Cancer Center Heidelberg (KiTZ)
Cornelis M van TilburgHeidelberg University Hospital
Cornelis M van TilburgNational Center for Tumor Diseases (NCT)
Cornelis M van TilburgClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Natalie J??gerHopp Children's Cancer Center Heidelberg (KiTZ)
Natalie J??gerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Natalie J??gerHopp Children's Cancer Center Heidelberg (KiTZ)
Natalie J??gerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Matthias SchlesnerGerman Cancer Research Center (DKFZ)
Matthias SchlesnerUniversity of Augsburg
Matthias SchlesnerGerman Cancer Research Center (DKFZ)
Matthias SchlesnerUniversity of Augsburg
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Till MildeNational Center for Tumor Diseases (NCT)
Till MildeHeidelberg University Hospital
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
  • 1 - 50

Datasets